Overview
- Rocket Lab's stock has moved lower in early June as the SpaceX IPO roadshow wrapped up, with final pricing expected Thursday night and trading slated to begin Friday, which shifted flows into and out of listed space companies.
- Company fundamentals remain strong with record Q1 revenue of about $200.35 million, roughly 63% year-over-year growth, and a contracted backlog near $2.2 billion, a performance CEO Peter Beck described as exceptional.
- Insider sales totaling about $18 million, including a large director sale in early June, have added supply pressure after the stock hit an all-time high near $151 on May 27.
- Commentators and traders are proposing option-income trades such as selling a Dec. 18 $110 cash-secured put that would generate about $2,825 of premium on an $11,000 reserve, a tactic that yields high income but carries clear assignment risk and a breakeven near $81.75.
- Technical indicators show a longer-term bullish trend with the stock trading well above its 100- and 200-day averages, yet near-term consolidation after May's run has raised focus on dilution risks from an up-to-$3 billion ATM equity facility and on longer-term catalysts like the Neutron program and a recent U.S. Space Force GEO contract.